Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.30 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.30 |
| ▸ | CHAT | P28329 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14290717 | 0.81 | FUT8 (0.50) | FUT8CA12CA1CA2CA9 | |
| SCHEMBL13809252 | 0.77 | FUT8 (0.34) | FUT8 | |
| SCHEMBL15452155 | 0.77 | CA1 (0.40) | CA12CA1CA2CA9APEX1 | |
| SCHEMBL15036163 | 0.76 | FUT8 (0.55) | FUT8MEN1THRBKMT2ACYP2C9 | |
| SCHEMBL9233802 | 0.75 | FUT8 (0.53) | FUT8CA12CA1CA2CA9 | |
| SCHEMBL5702813 | 0.75 | FUT8 (0.50) | FUT8CA12CA1CA2CA9 | |
| SCHEMBL30528721 | 0.75 | FUT8 (0.50) | FUT8CA12CA1CA2CA9 | |
| SCHEMBL8628445 | 0.73 | FUT8 (0.71) | FUT8MEN1THRBKMT2AALDH1A1 | |
| SCHEMBL8628450 | 0.73 | FUT8 (0.71) | FUT8MEN1THRBKMT2AALDH1A1 | |
| SCHEMBL7574337 | 0.73 | FUT8 (0.42) | FUT8CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7553340-B2 | Reactive dyes, a process for their preparation and their use | HUNTSMAN INTERNATIONAL, LLC (US) | 2009-06-30 | — | — | US | disclosed |
| US-20070294842-A1 | Reactive Dyes, a Process for Their Preparation and Their Use | HUNTSMAN INTERNATIONAL LLC | 2007-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070294842-A1 | Reactive Dyes, a Process for Their Preparation and Their Use | CBR3, ARSA, CBR1 | FUT8 885/4885CA12 1324/4885CA1 917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.